Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-076819

Options or other derivatives

  • President and CEO acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

USMAN NASSIM · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-10-22 Grant or award : show line 1 in the form Stock Option (Right to Buy) +71,428 $4.40 2025-10-22 71,428 71,428 D
2015-10-22 Grant or award : show line 2 in the form Stock Option (Right to Buy) +153,572 $4.40 2025-10-22 153,572 153,572 D
Loading xslF345X03/doc4.xml…